70010-907 : Penicillamine 250 mg Oral Capsule


NDC70010-907
Labeler: Granules Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name:  Penicillamine
Dosage Form: Oral Capsule
Application #: ANDA211735
Rev. Date: 


NDC Package Codes:

  • 70010-907-01: 100 CAPSULE IN 1 BOTTLE (70010‑907‑01)

Active Ingredients:

  • Penicillamine

Dosage Strength:

  • 250 mg

Pharmaceutical Classes:

  • Antirheumatic Agent [EPC]

Related Products:

Based on records with the same trade name.
  • 0254-2000 Penicillamine 250 mg Oral Tablet, Film Coated by Par Pharmaceutical, Inc.
  • 0591-4171 Penicillamine 250 mg Oral Capsule by Actavis Pharma, Inc.
  • 43598-634 Penicillamine 250 mg Oral Capsule, Gelatin Coated by Dr. Reddy's Laboratories Inc.
  • 43975-309 Penicillamine 250 mg Oral Capsule by Amerigen Pharmaceuticals, Inc.
  • 49884-146 Penicillamine 250 mg Oral Capsule by Par Pharmaceutical, Inc.
  • 51991-974 Penicillamine 250 mg Oral Capsule by Breckenridge Pharmaceutical, Inc.
  • 60505-4696 Penicillamine 250 1/1 Oral Capsule by Apotex Corp.
  • 62559-970 Penicillamine 250 mg Oral Capsule by Ani Pharmaceuticals, Inc.
  • 68475-201 Penicillamine 250 mg Oral Capsule by Navinta LLC
  • 68682-020 Penicillamine 250 mg Oral Capsule by Oceanside Pharmaceuticals
  • 70748-153 Penicillamine 250 1/1 Oral Tablet by Lupin Pharmaceuticals, Inc.
  • 71205-916 Penicillamine 250 mg Oral Capsule by Proficient Rx Lp
  • 72162-2112 Penicillamine 250 mg Oral Capsule by Bryant Ranch Prepack

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 70010-907 QR Code

< Prev: 70010-786Next: 70010-926 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.